OBJECTIVES: Comprehensive approach managing overall cardiovascular risk factors (i.e. blood glucose, blood pressure, and cholesterol level) is a core part of diabetes care; however, evidence describing type-2 diabetes (T2D) treatment in primary healthcare setting in China lacks. We aim to investigate the real-world drug utilization for T2D in a Chinese community population. METHODS: A retrospective database analysis was conducted. Data were obtained from Minhang community-based electronic medical record database, covering medical encounter records from community clinics/hospitals in Minhang district of Shanghai, China. Patients aged 18 or older, with T2D diagnosis or T2D medication prescription were included. Their demographics and drug utilization information between 1^st July 2014 and 30^thJune 2015 were analyzed using descriptive statistics. RESULTS: Totaling 41,186 T2D patients were identified, with mean age 67.3 (SD=10.3), 44.3% male, mean BMI 24.4 (SD=3.3) kg/mCONCLUSIONS: Among Chinese T2D patients in community hospitals under study, sulfonylureas and premix are primary choices of OAD and insulin, respectively. Hypertension and dyslipidemia are top comorbidities, but with insufficient management. Co-1st-author: Ke Wang, Yue Gao. Corresponding-author: Bao Liu.